Peter W. Swaan

12.0k total citations · 1 hit paper
129 papers, 6.9k citations indexed

About

Peter W. Swaan is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter W. Swaan has authored 129 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 51 papers in Molecular Biology and 23 papers in Pharmacology. Recurrent topics in Peter W. Swaan's work include Drug Transport and Resistance Mechanisms (61 papers), Pharmacogenetics and Drug Metabolism (16 papers) and RNA Interference and Gene Delivery (14 papers). Peter W. Swaan is often cited by papers focused on Drug Transport and Resistance Mechanisms (61 papers), Pharmacogenetics and Drug Metabolism (16 papers) and RNA Interference and Gene Delivery (14 papers). Peter W. Swaan collaborates with scholars based in United States, Netherlands and United Kingdom. Peter W. Swaan's co-authors include Sean Ekins, Hamidreza Ghandehari, Rohit Kolhatkar, Cheng Chang, Kelly M. Kitchens, Amy B. Foraker, Praveen M. Bahadduri, James E. Polli, Kathleen M. Hillgren and Lindsay C. Czuba and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Peter W. Swaan

128 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endocytic mechanisms for targeted drug delivery☆

2007 828 citations Peter W. Swaan et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter W. Swaan United States	44	2.9k	2.2k	892	792	787	129	6.9k
Duxin Sun United States	61	8.3k 2.9×	3.3k 1.5×	766 0.9×	357 0.5×	1.2k 1.5×	281	14.9k
Jarkko Rautio Finland	31	2.1k 0.7×	977 0.4×	375 0.4×	308 0.4×	614 0.8×	88	5.0k
Matthew D. Hall United States	51	4.9k 1.7×	5.3k 2.4×	276 0.3×	571 0.7×	936 1.2×	178	11.5k
Li Di United States	48	3.5k 1.2×	2.1k 1.0×	1.7k 1.9×	568 0.7×	350 0.4×	184	8.6k
Gergely Szakács Hungary	43	4.7k 1.6×	6.0k 2.8×	494 0.6×	1.1k 1.4×	861 1.1×	141	9.8k
Hilde Rosing Netherlands	56	4.6k 1.6×	6.7k 3.1×	1.6k 1.8×	1.5k 1.9×	738 0.9×	422	13.3k
Amit K. Tiwari United States	40	3.1k 1.1×	2.1k 1.0×	210 0.2×	320 0.4×	485 0.6×	215	6.5k
Dhananjay Pal United States	38	1.6k 0.5×	1.1k 0.5×	418 0.5×	467 0.6×	579 0.7×	165	5.1k
Enrico Mini Italy	50	3.2k 1.1×	5.2k 2.4×	388 0.4×	278 0.4×	376 0.5×	251	10.1k
Jamshidkhan Chamani Iran	64	5.2k 1.8×	1.8k 0.8×	220 0.2×	172 0.2×	642 0.8×	175	7.5k

Countries citing papers authored by Peter W. Swaan

Since Specialization

Citations

This map shows the geographic impact of Peter W. Swaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Swaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Swaan more than expected).

Fields of papers citing papers by Peter W. Swaan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Swaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Swaan. The network helps show where Peter W. Swaan may publish in the future.

Co-authorship network of co-authors of Peter W. Swaan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Swaan. A scholar is included among the top collaborators of Peter W. Swaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Swaan. Peter W. Swaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Czuba, Lindsay C., Kathleen M. Hillgren, & Peter W. Swaan. (2018). Post-translational modifications of transporters. Pharmacology & Therapeutics. 192. 88–99. 150 indexed citations

Köck, Kathleen, et al.. (2015). Toward Predicting Drug-Induced Liver Injury: Parallel Computational Approaches to Identify Multidrug Resistance Protein 4 and Bile Salt Export Pump Inhibitors. Drug Metabolism and Disposition. 43(5). 725–734. 26 indexed citations

Andar, Abhay, Renee R. Hood, Wyatt N. Vreeland, Don L. DeVoe, & Peter W. Swaan. (2013). Microfluidic Preparation of Liposomes to Determine Particle Size Influence on Cellular Uptake Mechanisms. Pharmaceutical Research. 31(2). 401–413. 132 indexed citations

Ghandehari, Hamidreza, et al.. (2013). Riboflavin-Targeted Polymer Conjugates for Breast Tumor Delivery. Pharmaceutical Research. 30(7). 1799–1812. 29 indexed citations

Köck, Kathleen, Brian C. Ferslew, Kyunghee Yang, et al.. (2013). Risk Factors for Development of Cholestatic Drug-Induced Liver Injury: Inhibition of Hepatic Basolateral Bile Acid Transporters Multidrug Resistance-Associated Proteins 3 and 4. Drug Metabolism and Disposition. 42(4). 665–674. 137 indexed citations

Swaan, Peter W., et al.. (2012). Putative Irreversible Inhibitors of the Human Sodium-Dependent Bile Acid Transporter (hASBT; SLC10A2) Support the Role of Transmembrane Domain 7 in Substrate Binding/Translocation. Pharmaceutical Research. 29(7). 1821–1831. 6 indexed citations

Lynch, Caitlin, Yongmei Pan, Linhao Li, et al.. (2012). Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches. Pharmaceutical Research. 30(2). 489–501. 33 indexed citations

Truong, David M., Gregory Kaler, Akash Khandelwal, Peter W. Swaan, & Sanjay K. Nigám. (2008). Multi-level Analysis of Organic Anion Transporters 1, 3, and 6 Reveals Major Differences in Structural Determinants of Antiviral Discrimination. Journal of Biological Chemistry. 283(13). 8654–8663. 82 indexed citations

Kolhatkar, Rohit, Kelly M. Kitchens, Peter W. Swaan, & Hamidreza Ghandehari. (2007). Surface Acetylation of Polyamidoamine (PAMAM) Dendrimers Decreases Cytotoxicity while Maintaining Membrane Permeability. Bioconjugate Chemistry. 18(6). 2054–2060. 232 indexed citations

10.

Ekins, Sean, Gerhard F. Ecker, Peter Chiba, & Peter W. Swaan. (2007). Future directions for drug transporter modelling. Xenobiotica. 37(10-11). 1152–1170. 37 indexed citations

11.

Khandelwal, Akash, Praveen M. Bahadduri, Cheng Chang, et al.. (2007). Computational Models to Assign Biopharmaceutics Drug Disposition Classification from Molecular Structure. Pharmaceutical Research. 24(12). 2249–2262. 43 indexed citations

12.

Kitchens, Kelly M., Amy B. Foraker, Rohit Kolhatkar, Peter W. Swaan, & Hamidreza Ghandehari. (2007). Endocytosis and Interaction of Poly (Amidoamine) Dendrimers with Caco-2 Cells. Pharmaceutical Research. 24(11). 2138–2145. 154 indexed citations

13.

Ray, Abhijit, et al.. (2006). Cytoskeletal scaffolds regulate riboflavin endocytosis and recycling in placental trophoblasts. The Journal of Nutritional Biochemistry. 17(12). 821–829. 8 indexed citations

14.

Ray, Abhijit, et al.. (2006). Design of novel synthetic MTS conjugates of bile acids for site-directed sulfhydryl labeling of cysteine residues in bile acid binding and transporting proteins. Bioorganic & Medicinal Chemistry Letters. 16(6). 1473–1476. 7 indexed citations

15.

Mason, Clifford, et al.. (2006). Recognition, Cointernalization, and Recycling of an Avian Riboflavin Carrier Protein in Human Placental Trophoblasts. Journal of Pharmacology and Experimental Therapeutics. 317(2). 465–472. 15 indexed citations

16.

Swaan, Peter W. & Sean Ekins. (2005). Reengineering the pharmaceutical industry by crash-testing molecules. Drug Discovery Today. 10(17). 1191–1200. 26 indexed citations

17.

Stinchcomb, Audra L., et al.. (2002). Straight-Chain Naltrexone Ester Prodrugs: Diffusion and Concurrent Esterase Biotransformation in Human Skin. Journal of Pharmaceutical Sciences. 91(12). 2571–2578. 60 indexed citations

18.

Zhang, Eric Y., Mitch A. Phelps, Cheng Chang, Sean Ekins, & Peter W. Swaan. (2002). Modeling of active transport systems. Advanced Drug Delivery Reviews. 54(3). 329–354. 56 indexed citations

19.

Muller, Mark T., et al.. (2001). Downregulation of topoisomerase I in differentiating human intestinal epithelial cells. International Journal of Cancer. 94(2). 200–207. 11 indexed citations

20.

Swaan, Peter W., et al.. (1994). Determination of Transport Rates for Arginine and Acetaminophen in Rabbit Intestinal Tissues in Vitro. Pharmaceutical Research. 11(2). 283–287. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact